EU Industry Benchmark
Pharma
Anonymized security posture data for the pharma sector across the EU. Based on 39 monitored sites.
49.1
Avg. Score /100
D
Avg. Grade
39
Sites Tracked
-9.0
vs. EU Average
Critical findings in this industry
5 of 39 without HTTPS redirect
1 of 39 with unencrypted email (no STARTTLS)
34 of 39 without DMARC protection (spoofable)
21 of 39 missing 3+ critical security headers
35 of 39 without DNSSEC (vulnerable to DNS spoofing)
36 of 39 without CAA records (unrestricted certificate issuance)
33 of 39 without MTA-STS (email downgrade attacks possible)
Grade Distribution
All data is anonymized. No individual sites are identified. Statistics updated weekly.